Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2013-12-31 01:30Chugai Pharma Invests $30 Million to Build China Marketing/Distribution
2013-12-29 01:30Week in Review: ChemPartner's Scientific Expertise
2013-12-28 01:30Exclusive Interview with Dr. Arthur Taveras: ChemPartner Focuses on Science and more...
2013-12-27 01:30Neurotron Raises $16.5 Million for Cochlear Implant Business and more...
2013-12-25 01:30Walvax to Gain Majority Control of Genor BioPharma for $49 Million
2013-12-24 01:30US FDA Grants Exclusivity/Fast Track Designations to TaiGen Antibiotic
2013-12-22 01:30Week in Review: First Novel China-Developed MAb Drug Gains CFDA Approval
2013-12-21 01:30Kanghong Pharma Gains CFDA Approval for China's First Innovative MAb and more...
2013-12-20 01:30Simcere Gains Shareholder Approval for Privatization Offer
2013-12-19 01:30GSK Institutes Changes to Pay Rules for Sales Force and Doctors and more...
2013-12-18 01:30Alvogen Pays $210 Million for 67% of Taiwan's Lotus Pharma and more...
2013-12-17 01:30China Arrests 1,300 in Raids on Fake-Drug Businesses
2013-12-15 01:30Week in Review: Consun Pharma to IPO in Hong Kong, Raising $141 Million
2013-12-14 01:30Senhwa Biosciences Raises $17 Million to Develop Cancer Drugs and more...
2013-12-13 01:30Consun Pharma Schedules Hong Kong IPO and more...
2013-12-12 01:30MTIA In-licenses China Rights to Innovative Glucose Monitoring System and more...
2013-12-11 01:30Shanghai Official Detained in GlaxoSmithKline Scandal
2013-12-10 01:30China Agrees to Allow Ten Additional US FDA Inspectors
2013-12-08 01:30Week in Review: China Pharmas Make Cross-Border Deals with the West
2013-12-07 01:30Beijing Union Signs MOU for IXICO's Dementia Neuroimaging Technology
2013-12-06 01:30Helsinn Group Opens China Office
2013-12-05 01:30Zhejiang Hisun to Raise $328 Million to Increase Capacity
2013-12-04 01:30Hebei University Company In-licenses Cancer Molecule from Sareum of Britain and more...
2013-12-03 01:30China Pioneer Pharma to Invest $5.7 Million in NovaBay for Distribution Rights
2013-12-01 01:30Week in Review: BioPacific to Make Angel Investments in China/Asia

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC